Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: SRI INTERNATIONAL
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2011-07-01 to 2016-06-30
Current total value of award: $1158784.13
Description: PRECLINICAL PHARMACOKINETIC AND PHARMACOLOGICAL STUDIES WITH ANTICANCER & OTHER THERAPEUTIC AGENTS